How is Everolimus reimbursed by medical insurance? How much?

Everolimus (Everolimus) is a targeted therapy drug that belongs to a class of immunosuppressants and is used to treat a variety of diseases. Its mechanism of action is to inhibit the mammalian target of rapamycin (mTOR) signaling pathway and interfere with the growth, division and spread of cancer cells or abnormal cells, thereby achieving the purpose of treatment.

Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.

Everolimus was first used for immunosuppression after organ transplantation to reduce the chance of the immune system attacking the transplanted organ and improve the success rate of transplantation. It suppresses the activity of the immune system, reduces rejection reactions, and helps organ transplant patients better adapt to their new organs.

In addition, everolimus is used to treat certain types of cancer. In breast cancer, it is often used in combination with hormonal therapy to treat hormone receptor-positive (ER+) and HER2-negative breast cancer, especially when patients are resistant to hormonal therapy. For neuroendocrine tumors, everolimus can slow down the growth and spread of tumors and improve patient survival. Additionally, it is used in the treatment of meningiomas associated with tuberous sclerosis complex (TSC).

The use of everolimus needs to be done under the guidance of a doctor, because it may be accompanied by some side effects, such as oral ulcers, rash, fatigue, nausea, diarrhea, etc. The doctor will develop a personalized treatment plan and adjust the drug dosage based on the patient's specific situation to achieve the best therapeutic effect and minimal discomfort.

In general, everolimus is a targeted therapy drug that targets the molecular targets of specific diseases by inhibiting the mTOR signaling pathway to achieve the effect of inhibiting disease progression. It has important application value in organ transplantation and cancer treatment, but it needs to be used under the guidance of a doctor.